Eko is a pioneering healthcare technology company that develops AI and digital tools aimed at enhancing the detection of heart and lung diseases, which are among the leading causes of death worldwide. With a strong commitment to quality and innovation, Eko's FDA-cleared products are utilized by hundreds of thousands of clinicians globally, enabling them to diagnose and manage cardiac and pulmonary conditions with greater accuracy and confidence. Backed by prominent venture capital firms and recognized by TIME magazine as one of the top healthcare technology companies, Eko is rapidly growing and is dedicated to ensuring that all patients have access to high-quality care. The company fosters a mission-driven culture with a diverse team of professionals, including engineers, physicians, and technologists, all working collaboratively to advance healthcare solutions. Headquartered in Emeryville, California, Eko is privately held and focused on continuous research and development to deliver exceptional products for patient care.